Clinical Trials in New York State

Showing 5601-5620 of 17,167 trials

Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery

NCT06128369

The goal of this clinical trial is to evaluate the efficacy and safety of OCS-01 in treating inflammation and pain in subjects following cataract surgery.

Inflammation EyePain, PostoperativeCataract

Oculis117 participantsStarted Dec 2023

Inglewood, California, United States • Morrow, Georgia, United States • Louisville, Kentucky, United States +9 more locations

TERMINATEDPhase 392 miles

A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations

NCT02588261

The purpose of the study was to evaluate the progression free survival (PFS), based on independent radiologic review (IRR), of ASP8273 compared to erlotinib or gefitinib in patients with locally advanced, metastatic or unresectable stage IIIB/IV adenocarcinoma non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutations. This study also assessed Overall survival (OS); Overall response rate (ORR) as assessed by IRR; PFS as assessed by the investigator; Disease control rate (DCR) as assessed by IRR; Duration of Response (DOR) by IRR; Safety of ASP8273; and Quality of Life (QOL) and patient-reported outcome (PRO) parameters.

Non-small Cell Lung Cancer (NSCLC)

Astellas Pharma Global Development, Inc.530 participantsStarted Feb 2016

Beverly Hills, California, United States • Fountain Valley, California, United States • La Jolla, California, United States +164 more locations

Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery

A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations

Find Trials by Condition in New York State

realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease

Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)

SpineJack System Postmarket Registry

Study of PULSAR-ICI +/- IMSA101 in Patients with Oligoprogressive Solid Tumor Malignancies

Pragmatic Trial Examining Oxygenation Prior to Intubation

IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)

Safety, PK/PD, and Clinical Activity of KT-413 in Adult Patients with Relapsed or Refractory B-cell NHL

ET-01 in Subjects With Lateral Canthal Lines, LCL-210

Efficacy Trial of the CALM Intervention

A Phase III Trial of e-TNS for the Acute Treatment of Migraine

Osia 2 Pediatric Expansion Study

GKT137831 in IPF Patients with Idiopathic Pulmonary Fibrosis

A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2

De-Implementation of Unnecessary Surgical Antibiotic Prophylaxis in Children

A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)

Honest, Open, Proud for Soldiers with Mental Illness